We are live on ! Find out more
DCP

Distillate Capital Partners Portfolio holdings

AUM $1.9B
1-Year Est. Return 2.22%
This Fund
S&P 500
This Quarter Est. Return
-1.16%
1 Year Est. Return
-2.22%
3 Year Est. Return
+17.78%
5 Year Est. Return
+50.1%
10 Year Est. Return
–
AUM
$376M
AUM Growth
+$16.1M
Cap. Flow
+$24.9M
Cap. Flow %
6.62%
Top 10 Hldgs %
20.86%
Holding
140
New
26
Increased
73
Reduced
11
Closed
30

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$4.74M
2
ADP icon
Automatic Data Processing
ADP
+$3.73M
3
NSC icon
Norfolk Southern
NSC
+$3.38M
4
APH icon
Amphenol
APH
+$3.32M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.31M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$7.95M
2
AAPL icon
Apple
AAPL
+$7.53M
3
BLK icon
Blackrock
BLK
+$4.32M
4
TMO icon
Thermo Fisher Scientific
TMO
+$4.28M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$3.59M

Sector Composition

Rank Sector Weight
1 Technology 23.47%
2 Healthcare 21.25%
3 Industrials 19.44%
4 Consumer Discretionary 12.31%
5 Consumer Staples 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITW icon
51
Illinois Tool Works
ITW
$85.2B
$3.24M 0.86%
15,695
+2,245
+17% +$506K
NTAP icon
52
NetApp
NTAP
$37.5B
$3.23M 0.86%
36,001
+503
+1% +$42.5K
FANG icon
53
Diamondback Energy
FANG
$52.8B
$3.19M 0.85%
33,648
-3,530
-9% -$284K
NSC icon
54
Norfolk Southern
NSC
$76.3B
$3.16M 0.84%
+13,196
New +$3.38M
LH icon
55
Labcorp
LH
$25.4B
$3.14M 0.84%
12,986
+606
+5% +$153K
RHI icon
56
Robert Half
RHI
$4.16B
$3.09M 0.82%
+30,801
New +$3.01M
VRTX icon
57
Vertex Pharmaceuticals
VRTX
$124B
$3.07M 0.82%
+16,946
New +$3.31M
CMI icon
58
Cummins
CMI
$90.7B
$3.06M 0.81%
13,617
+2,610
+24% +$612K
CPAY icon
59
Corpay
CPAY
$26B
$3M 0.8%
11,501
+1,628
+16% +$421K
WLK icon
60
Westlake Corp
WLK
$9.71B
$3M 0.8%
+32,908
New +$2.82M
PH icon
61
Parker-Hannifin
PH
$127B
$2.98M 0.79%
10,655
+1,716
+19% +$511K
LKQ icon
62
LKQ Corp
LKQ
$6.15B
$2.96M 0.79%
58,769
-1,872
-3% -$95.3K
BRO icon
63
Brown & Brown
BRO
$23.8B
$2.94M 0.78%
52,940
-2,466
-4% -$137K
FFIV icon
64
F5
FFIV
$23.4B
$2.93M 0.78%
14,745
+2,790
+23% +$558K
SSNC icon
65
SS&C Technologies
SSNC
$19B
$2.93M 0.78%
+42,171
New +$3.13M
HSIC icon
66
Henry Schein
HSIC
$10.1B
$2.92M 0.78%
+38,342
New +$2.95M
BIIB icon
67
Biogen
BIIB
$31.2B
$2.91M 0.78%
10,299
-746
-7% -$245K
ATVI
68
DELISTED
Activision Blizzard
ATVI
$2.91M 0.78%
37,654
+4,646
+14% +$388K
CE icon
69
Celanese
CE
$4.59B
$2.91M 0.77%
19,302
+1,968
+11% +$303K
AAP icon
70
Advance Auto Parts
AAP
$3.63B
$2.88M 0.77%
13,793
+60
+0.4% +$12.5K
WRK
71
DELISTED
WestRock Company
WRK
$2.85M 0.76%
57,314
+5,788
+11% +$292K
PCAR icon
72
PACCAR
PCAR
$71.7B
$2.82M 0.75%
53,614
+8,922
+20% +$495K
CHD icon
73
Church & Dwight Co
CHD
$24.4B
$2.8M 0.74%
33,868
+4,322
+15% +$366K
ROST icon
74
Ross Stores
ROST
$81.2B
$2.75M 0.73%
25,279
+2,551
+11% +$306K
DOX icon
75
Amdocs
DOX
$5.95B
$2.73M 0.73%
+36,072
New +$2.79M
1 2
3
4 5

Similar funds

EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM

Distillate Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Distillate Capital Partners held 140 positions worth $376M, up 4.5% from $360M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Distillate Capital Partners deployed $24.9M of net new capital in Q3 2021, opening 26 new positions and adding to 73 existing holdings. Its largest new stake was Elevance Health: 12,461 shares worth $4.64M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Bath & Body Works, an estimated $715K trimmed.

  • Distillate Capital Partners's largest Q3 2021 buy was Elevance Health: 12,461 shares worth $4.64M.
  • Distillate Capital Partners added most to Johnson & Johnson in Q3 2021, an estimated $2.55M increase.
  • Distillate Capital Partners's biggest Q3 2021 reduction was Bath & Body Works, cutting an estimated $715K.
  • Distillate Capital Partners fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $7.95M.
  • Distillate Capital Partners's ten largest holdings make up 21% of its $376M portfolio in Q3 2021.
  • Distillate Capital Partners opened 26 new positions and closed 30 in Q3 2021.
  • Distillate Capital Partners's portfolio value rose 4.5% quarter-over-quarter to $376M.

Based on Distillate Capital Partners's 13F filing for Q3 2021, filed 5 Nov 2021.